Urovant Sciences Ltd. IPO Research Information

Urovant Sciences Ltd. IPO Advisory

Share this IPO Profile:

Smart Search

For IPO Boutique's "scale of 1 to 5" BUY rating on Urovant Sciences Ltd., and our comprehensive analysis, click "Buy Market Research".

Company	Symbol	Price Range	Issue Price	Open	Shares	Trade Date
Urovant Sciences Ltd.	UROV - NASDAQ	$14.00-$16.00	$14.00	$10.50	10 million	9/27/2018
Underwriter(s): J.P. Morgan, Jefferies, Cowen
Co-Manager(s):
Industry: Health Care
Filing(s): Filed 2018-07-13 Updated Prospectus 2018-08-15 Terms Added 2018-09-17

Urovant Sciences Ltd. Quote & Chart - Click for current quote - UROV

About Urovant Sciences Ltd. (adapted from Urovant Sciences Ltd. prospectus):
They are a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapies for urologic conditions.

This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.

IPO Boutique aggregates information on public companies and private companies, such as "UROV" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.